Breaking News Instant updates and real-time market news.

TEVA

Teva

$6.55

0.02 (0.31%)

12:15
10/09/19
10/09
12:15
10/09/19
12:15

Teva put volume heavy and directionally bearish

Bearish flow noted in Teva with 21,716 puts trading, or 2x expected. Most active are Nov-19 6 puts and Oct-19 6 puts, with total volume in those strikes near 16,200 contracts. The Put/Call Ratio is 5.29, while ATM IV is up over 4 points on the day. Earnings are expected on November 7th.

  • 07

    Nov

TEVA Teva
$6.55

0.02 (0.31%)

08/08/19
RHCO
08/08/19
NO CHANGE
Target $7
RHCO
Hold
Teva price target lowered to $7 from $10 at SunTrust
SunTrust analyst Gregg Gilbert lowered his price target on Teva to $7 and kept his Hold rating in spite of its Q2 earnings beat. The analyst says the quarter was decent with "continued stability" seen in North America generics, but he is concerned about the perception of the departure of Teva's CEO. Gilbert also points to Teva becoming the first company in his coverage to reserve a sum for potential opioid settlements.
09/11/19
GUGG
09/11/19
INITIATION
GUGG
Neutral
Teva assumed with a Neutral at Guggenheim
Guggenheim analyst Dana Flanders assumed coverage of Teva Pharmaceuticals with a Neutral rating and a $6-$8 fair value range, saying that "expectations for global generics appear right sized." Flanders believes the company should be able to meaningfully address its debt over the next 3-5 years, but noted it will also have to contend with opioid litigation and price collusion litigation that cost $4B-$8B and $1B, respectively. He added that Teva will need to address both its branded pipeline and biosimilars in the medium-term future.
09/30/19
WELS
09/30/19
NO CHANGE
Target $8
WELS
Market Perform
Teva price target lowered to $8 from $17 at Wells Fargo
Wells Fargo analyst David Maris lowered his price target for Teva to $8 from $17 as he lowered his earnings outlook for 2020 and beyond. The analyst is now including approximately $3 of liability in his valuation that he did not include before. Maris understands how some investors would be buying Teva shares with the idea that the outcome of the opioid and price fixing situations will be more manageable than feared, however he has no particular insight into a potential settlement and continues to have questions as to the timing of the earnings and margin trough. The analyst reiterates a Market Perform rating on the shares.
10/03/19
PIPR
10/03/19
NO CHANGE
Target $29
PIPR
Overweight
Bausch unlikely to face generic Xifaxan before 2028, says Piper Jaffray
Piper Jaffray analyst David Amsellem says he would not be worried that a generic Xifaxan entrant will emerge prior to the January 2028 launch date outlined in Bausch Health Companies' (BHC) settlement with Teva (TEVA) on its generic filing. The analyst highlights the "relatively complex nature" of Xifaxan and Bausch's "fairly deep intellectual property estate." As such, he continues to believe that visibility into a "durable" EBITDA for Bausch Health is high, with a longer-term annual growth "reaching at least the high single digits." He reiterates an Overweight rating on the shares with a $29 price target.

TODAY'S FREE FLY STORIES

SAN

Banco Santander

$4.36

0.055 (1.28%)

16:49
10/21/19
10/21
16:49
10/21/19
16:49
Hot Stocks
Santander to sell Puerto Rico franchise to FirstBank Puerto Rico for $1.1B »

Santander announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QTNT

Quotient

$8.13

-0.33 (-3.90%)

16:48
10/21/19
10/21
16:48
10/21/19
16:48
Conference/Events
Quotient management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 04

    Nov

TNP

TEN, Ltd.

$3.82

-0.02 (-0.52%)

16:48
10/21/19
10/21
16:48
10/21/19
16:48
Syndicate
Breaking Syndicate news story on TEN, Ltd. »

TEN, Ltd. files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCAR

Paccar

$72.88

0.83 (1.15%)

16:47
10/21/19
10/21
16:47
10/21/19
16:47
Conference/Events
Paccar management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

FBK

FB Financial

$37.96

0.22 (0.58%)

16:46
10/21/19
10/21
16:46
10/21/19
16:46
Earnings
FB Financial reports Q3 adjusted EPS 77c, consensus 72c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

16:45
10/21/19
10/21
16:45
10/21/19
16:45
General news
Treasury Market Summary »

Treasury Market Summary:…

CSL

Carlisle

$145.24

1.99 (1.39%)

16:41
10/21/19
10/21
16:41
10/21/19
16:41
Hot Stocks
Carlisle to acquire Providien, terms not stated »

Carlisle announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

  • 13

    Nov

  • 18

    Nov

  • 19

    Nov

GOOG

Alphabet

$1,246.24

-0.32 (-0.03%)

, MSFT

Microsoft

$138.43

1.09 (0.79%)

16:41
10/21/19
10/21
16:41
10/21/19
16:41
Periodicals
Google hires former Microsoft exec Javier Soltero to lead G suite, CNBC says »

CNBC's Jennifer…

GOOG

Alphabet

$1,246.24

-0.32 (-0.03%)

MSFT

Microsoft

$138.43

1.09 (0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 26

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 21

    Nov

TEUM

Pareteum

$0.74

-0.0948 (-11.42%)

16:40
10/21/19
10/21
16:40
10/21/19
16:40
Hot Stocks
Pareteum to restate previously issued financial statements »

Pareteum announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

CDNS

Cadence Design

$66.67

1.07 (1.63%)

16:38
10/21/19
10/21
16:38
10/21/19
16:38
Hot Stocks
Breaking Hot Stocks news story on Cadence Design »

Cadence Design up 4.5% at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 06

    Nov

  • 19

    Nov

MIST

Milestone Pharmaceuticals

$21.60

2.1 (10.77%)

16:38
10/21/19
10/21
16:38
10/21/19
16:38
Conference/Events
Milestone Pharmaceuticals management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

CE

Celanese

$121.37

-0.3 (-0.25%)

16:37
10/21/19
10/21
16:37
10/21/19
16:37
Hot Stocks
Breaking Hot Stocks news story on Celanese »

Celanese down 2.8% at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

CE

Celanese

$121.37

-0.3 (-0.25%)

16:36
10/21/19
10/21
16:36
10/21/19
16:36
Earnings
Celanese sees FY20 EPS $11-$12 , consensus $11.25 »

The company states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

HMST

HomeStreet

$28.66

0.27 (0.95%)

16:36
10/21/19
10/21
16:36
10/21/19
16:36
Hot Stocks
HomeStreet board approves additional share buyback of up to $25M »

HomeStreet said its board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

GME

GameStop

$5.93

-0.02 (-0.34%)

16:35
10/21/19
10/21
16:35
10/21/19
16:35
Conference/Events
GameStop management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

HSTM

HealthStream

$26.33

0.13 (0.50%)

16:35
10/21/19
10/21
16:35
10/21/19
16:35
Earnings
HealthStream sees FY19 revenue $252M-$256M, consensus $255.46M »

Sees FY19 Adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

CE

Celanese

$121.37

-0.3 (-0.25%)

16:35
10/21/19
10/21
16:35
10/21/19
16:35
Earnings
Celanese cuts FY19 EPS view to $9.60-$9.80 from 'see path to $10.50' 

Consensus $10.14.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

HMST

HomeStreet

$28.66

0.27 (0.95%)

16:35
10/21/19
10/21
16:35
10/21/19
16:35
Earnings
HomeStreet reports Q3 EPS 54c, consensus 33c »

"Homestreet's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

CE

Celanese

$121.37

-0.3 (-0.25%)

16:34
10/21/19
10/21
16:34
10/21/19
16:34
Hot Stocks
Celanese says market conditions unlikely to improve in 2019 »

The company's says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

OSB

Norbord

$26.75

0.36 (1.36%)

16:33
10/21/19
10/21
16:33
10/21/19
16:33
Hot Stocks
Norbord to indefinitely curtail production on Line 1 at Cordele OSB mill »

Nobord announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSTM

HealthStream

$26.33

0.13 (0.50%)

16:33
10/21/19
10/21
16:33
10/21/19
16:33
Earnings
HealthStream reports Q3 EPS 11c, consensus 6c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

UGI

UGI Corporation

$48.25

0.07 (0.15%)

16:32
10/21/19
10/21
16:32
10/21/19
16:32
Conference/Events
UGI Corporation management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 12

    Nov

BXS

BancorpSouth

$29.66

0.17 (0.58%)

16:32
10/21/19
10/21
16:32
10/21/19
16:32
Earnings
BancorpSouth reports Q3 net operating EPS 69c, consensus 61c »

Net interest margin -…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

TD

Toronto-Dominion

$56.80

0.34 (0.60%)

, AMTD

TD Ameritrade

$37.64

0.85 (2.31%)

16:32
10/21/19
10/21
16:32
10/21/19
16:32
Hot Stocks
TD Bank comments on expected impact of TD Ameritrade Q4 earnings »

TD Bank Group (TD)…

TD

Toronto-Dominion

$56.80

0.34 (0.60%)

AMTD

TD Ameritrade

$37.64

0.85 (2.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 27

    Oct

SECO

Seeco Holding

$6.15

0.2 (3.36%)

16:31
10/21/19
10/21
16:31
10/21/19
16:31
Conference/Events
Seeco Holding management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.